User account menu Search Menu Home Investors Share Data & Analysis Share Ownership Share Ownership The following tables relate only to registered shareholders and cannot be assumed to represent the entire investor base because nominees and JPMorgan Chase Bank, N.A., as ADS depositary, are registered as shareholders for a large number of beneficial owners. As of December 31, 2020, Novartis AG had approximately 176 000 registered shareholders Registered shareholders by type As of December 31, 2020 Shareholders in % Shares in % Individual shareholders 96.61 14.00 Legal entities1 3.34 34.51 Nominees, fiduciaries and ADS depositary 0.05 51.49 Registered shareholders by country2 As of December 31, 2020 Shareholders in % Shares in % Belgium 0.12 1.03 France 2.01 0.31 Germany 5.68 1.80 Japan 0.20 0.59 Luxembourg 0.06 0.69 Switzerland1 87.45 44.08 United Kingdom 0.59 25.09 United States 0.28 24.36 Other countries 3.61 2.05 Excluding 4.3% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries Registered shares held by nominees are shown in the country where the company/affiliate entered in the Share Register as shareholder has its registered seat. Related Links Share Overview Share Monitor Share Data & Analysis Novartis Registered Shares Novartis Navigate Patients and Caregivers Healthcare Professionals Researchers Job Seekers Journalists Investors Partners Suppliers Topics Clinical Trials COVID-19 Info Center ESG Explore Stories Diseases Locations Companies Sandoz Advanced Accelerator Applications Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience

User account menu Search Menu Home Investors Shareholder Information General Meetings General Meetings English Deutsch Français 2021 2020 2019 2018 2017 2016 Archive 2022 Annual General Meeting Date: Friday, March 4, 2022 Place: Basel, Switzerland Agenda and Instructions Request to include an Agenda item (PDF 0.2 MB) Novartis Navigate Patients and Caregivers Healthcare Professionals Researchers Job Seekers Journalists Investors Partners Suppliers Topics Clinical Trials COVID-19 Info Center ESG Explore Stories Diseases Locations Companies Sandoz Advanced Accelerator Applications Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience